| Bernadette Georgette Letsa, NP | |
|
8257 Gypsy Star Way, Sacramento, CA 95829-6109 | |
| (909) 241-6053 | |
| Not Available |
| Full Name | Bernadette Georgette Letsa |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 8257 Gypsy Star Way, Sacramento, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023780822 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | NP95018123 (California) | Primary |
| Entity Name | Pain Clinics Of Central California, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861060733 PECOS PAC ID: 0244615086 Enrollment ID: O20220915001235 |
News Archive
Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.
Hypertension is a serious condition affecting millions.Currently there are seven classes of drugs used to reduce blood pressure. Aliskiren (Tekturna , Rasilez) is the first of a new class of orally active antihypertensive drugs that works by inhibiting renin.
In their pursuit of maximum reward, people suffering from gambling disorder rely less on exploring new but potentially better strategies, and more on proven courses of action that have already led to success in the past.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bernadette Georgette Letsa, NP 8257 Gypsy Star Way, Sacramento, CA 95829-6109 Ph: (909) 241-6053 | Bernadette Georgette Letsa, NP 8257 Gypsy Star Way, Sacramento, CA 95829-6109 Ph: (909) 241-6053 |
News Archive
Results from a Phase 2, 8-week dose-ranging study using low doses of atrasentan in patients with diabetic kidney disease were published this week in the Journal of the American Society of Nephrology. The published study results suggest that atrasentan, used in conjunction with renin-angiotensin system inhibitors, may reduce albuminuria (presence of protein in urine) for patients with type 2 diabetes.
Hypertension is a serious condition affecting millions.Currently there are seven classes of drugs used to reduce blood pressure. Aliskiren (Tekturna , Rasilez) is the first of a new class of orally active antihypertensive drugs that works by inhibiting renin.
In their pursuit of maximum reward, people suffering from gambling disorder rely less on exploring new but potentially better strategies, and more on proven courses of action that have already led to success in the past.
FibroGen, Inc. (FibroGen) announced today the presentation of clinical data at the American Thoracic Society (ATS) International Conference supporting the safety and efficacy of FG-3019 in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and life-threatening lung disease for which there is currently no approved therapy in the United States.
ProFibrix B.V., a leader in the development of innovative bioactive products to stop bleeding (hemostasis), today announced the start of its pivotal Phase III clinical trial with Fibrocaps (FINISH-3) in spine, liver, vascular and soft tissue surgery.
› Verified 9 days ago
Sumon Johnson, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2570 48th St, Sacramento, CA 95817 Phone: 916-734-2145 | |
Sharon Kay Mccoy, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-6935 | |
Frances Eileen Briare, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6600 Bruceville Rd, Sacramento, CA 95823 Phone: 916-688-2000 | |
Ms. Patricia Lynne Kang, GNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6600 Bruceville Rd, Eldercare Adult Medicine F, Sacramento, CA 95823 Phone: 916-688-6862 Fax: 916-973-6682 | |
Ashena Varani, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3840 Watt Ave, Suite E, Sacramento, CA 95821 Phone: 916-488-6200 Fax: 916-488-6300 | |
Stella Morden, PHD, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1500 21st St, Sacramento, CA 95811 Phone: 916-914-6358 | |
Yiching Gibson, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2315 Stockton Blvd, Sacramento, CA 95817 Phone: 916-734-4644 |